-
-
- 소 속: 분당차병원
-
전문분야
: 간암/췌담도암
- 직 위: 부교수(암센터장)
- 메 일: 비공개
- 전 화: 1577-4488
- 팩 스:
- 주 소: 경기도 성남시 분당구 야탑동 351번지
- 홈페이지:
탭메뉴
주요발표논문
| 번호 |
구분 |
제목 |
다운로드 |
| 25 |
해외 |
The Korean experience of FOLFIRINOX in pancreatic cancer (International Pancreatic Cancer Forum, Taipei, Taiwan, 2019) |
|
| 24 |
해외 |
Immunotherapy and biomarkers in hepatocellular carcinoma (KSMO 2019, Seoul, Korea, 2019) |
|
| 23 |
해외 |
Adjuvant therapy and neoadjuvant therapy for cancer (KPSC-KCSG Joint Symposium, Seoul, Korea, 2019) |
|
| 22 |
해외 |
Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma. (Gastrointestinal Cancer Symposium, San Francisco, CA, United States, 2020) |
|
| 21 |
해외 |
Different organ-specific response to nivolumab to determine the survival outcome of patients with advanced hepatocellular carcinoma (aHCC) (ASCO Annual Meeting, Virtual, 2020) |
|
| 20 |
해외 |
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the 2nd line chemotherapy for patients with metastatic pancreatic cancer; multicenter study of the Korean Cancer Study Group (KCSG) (ASCO Annual Meeting, Virtual, 2020) |
|
| 19 |
해외 |
Early safety from a phase 1, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into liver tumors in combination with pembrolizumab (pem) (ASCO Annual Meeting, Virtual, 2020) |
|
| 18 |
해외 |
Artificial intelligence with a deep learning technology enables a rational development of a potent immunotherapeutic agent. (AACR Annual Meeting, Virtual, 2020) |
|
| 17 |
해외 |
Oncolytic vaccinia virus and checkpoint inhibitor combination therapy (PCT/US2018/028952, 2018) |
|
| 16 |
해외 |
Novel IDO/TDO inhibitors (62647483, 2018) |
|
1
2
3
4
5
6
7
8
Copyright ⓒ chamc, All rights reserved.
